Wegovy vs Mounjaro: Mechanism, Dosing & Pricing Breakdown
Understanding the Core Difference Between Wegovy and Mounjaro UK Mechanisms
The fundamental difference between Wegovy and Mounjaro UK lies in their receptor targeting mechanisms. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote satiety after smaller meals. Mounjaro, containing tirzepatide, functions as a dual receptor agonist targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously. This dual mechanism may provide different appetite control patterns, though both work on brain appetite centres to reduce food cravings. Your individual response to either GLP-1 alone or the dual GIP/GLP-1 approach cannot be predicted without clinical trial under medical supervision.
Both medications require weekly injections using pre-filled pens and must be prescribed alongside lifestyle modifications including reduced-calorie diet and increased physical activity. The difference between Wegovy and Mounjaro UK extends to their molecular structures, with tirzepatide being a novel dual agonist whilst semaglutide represents the established GLP-1 class. Neither medication works as a standalone solution, and both require ongoing medical supervision through our GPhC-registered pharmacy (#9012878). Clinical assessment determines suitability for either treatment based on your BMI, medical history, and weight-related comorbidities.
Difference Between Wegovy and Mounjaro UK Pricing and Value Comparison
Understanding the cost difference between Wegovy and Mounjaro UK helps inform your treatment decision alongside clinical considerations. Wegovy pricing starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. Our bundle options include the Intro Duo (0.25mg & 0.5mg) for £169.99 and the Ultimate Stability Trio (three 2.4mg pens) for £649.99. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Mounjaro follows a different dosing structure with six escalation steps from 2.5mg to 15mg, requiring comparison based on your prescribed treatment pathway rather than dose-for-dose pricing.
Bundle pricing provides convenience through Reliable Supply and fewer ordering requirements rather than direct savings calculations. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99 and covers three months of dose escalation with single delivery convenience. Express prescriber review is available within 24 hours for £15 additional cost when you need faster treatment initiation. Both Wegovy and Mounjaro qualify for our next-day cold-chain delivery service once your prescription is approved, ensuring temperature-controlled transport from our GPhC-registered facility.
Clinical Evidence Comparing Wegovy vs Mounjaro UK Effectiveness
Clinical trials demonstrate both treatments' effectiveness when used alongside diet and exercise modifications. In the STEP trials, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 trial showed 9.6% weight reduction in patients with type 2 diabetes, whilst STEP 3 demonstrated clinically studied weight loss with intensive behavioural therapy. These results cannot ensure individual outcomes and represent average findings across diverse patient populations.
Mounjaro's SURMOUNT trials showed different percentage outcomes, though direct comparison between trials isn't scientifically valid due to different study designs, patient populations, and endpoints. Both medications showed cardiovascular benefits in their respective outcome studies, with Wegovy's SELECT trial demonstrating 20% reduction in major cardiovascular events. The difference between Wegovy and Mounjaro UK clinical profiles may influence prescriber recommendations based on your individual risk factors and treatment goals.
How Wegovy Works: GLP-1 Receptor Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking glucagon-like peptide-1, a natural hormone your intestines release after eating. This mechanism slows gastric emptying, meaning food stays in your stomach longer, promoting earlier and longer-lasting feelings of fullness after smaller meals. The medication also acts directly on appetite control centres in your hypothalamus, potentially reducing food cravings and the psychological drive to eat. Wegovy enhances insulin sensitivity and glucose-dependent insulin release, though it's licensed specifically for weight management rather than diabetes treatment. Weekly dosing maintains consistent hormone levels, with the 2.4mg maintenance dose typically reached after 16 weeks of gradual escalation. This systematic approach minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's appetite-suppressing effects.
EverydayMeds Ordering Process: Assessment to Delivery
Our streamlined process begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and contraindications for either Wegovy or Mounjaro. Qualified prescribers review your assessment within standard 3 working days, or within 24 hours if you select express review for £15 additional cost. Once approved, your prescription enters our cold-chain dispatch system for next-day delivery in temperature-controlled packaging. Our GPhC-registered pharmacy (#9012878) ensures all medications meet MHRA standards with full batch tracking and authenticity verification. You'll receive injection technique guidance, dose escalation schedules, and ongoing support through your treatment journey with both medications available through our secure online platform.
Storage and Practical Differences: Wegovy vs Mounjaro UK Convenience
A significant practical difference between Wegovy and Mounjaro UK involves storage requirements and travel convenience. Wegovy pens maintain potency for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy more convenient for business travel, holidays, or situations where refrigeration access is limited. Both medications require initial storage at 2-8°C and use similar injection pen technology, though Wegovy employs Novo Nordisk's FlexTouch pen system. Weekly injection scheduling remains consistent between both treatments, with most patients preferring the same day each week for routine establishment. The difference between Wegovy and Mounjaro UK storage capabilities may influence treatment choice for frequent travellers or those with limited refrigeration access.
Dual Receptor vs Single Receptor: Which Mechanism Suits UK Patients Better
The theoretical advantage of Mounjaro's dual GIP/GLP-1 mechanism versus Wegovy's single GLP-1 targeting remains individual and unpredictable until treatment initiation. Some patients may respond better to the established GLP-1 pathway that Wegovy provides, whilst others might benefit from the additional GIP receptor stimulation that Mounjaro offers. UK prescribers often consider factors like previous GLP-1 experience, diabetes status, and individual appetite patterns when recommending between treatments. Neither mechanism is inherently superior, and the difference between Wegovy and Mounjaro UK effectiveness varies significantly between individuals.
Both treatments require identical lifestyle commitments including reduced-calorie diet and increased physical activity for optimal results. The choice often comes down to practical considerations like storage requirements, dosing schedules, and individual tolerability rather than mechanism superiority. Clinical studies cannot predict which patient will respond better to single versus dual receptor targeting, making supervised trial the only definitive way to determine optimal treatment response.
Making Your Choice: Both Available from EverydayMeds
Both Wegovy and Mounjaro are available through EverydayMeds with identical clinical assessment processes, prescriber review standards, and cold-chain delivery services. Your choice depends on individual factors including medical history, lifestyle requirements, storage needs, and prescriber recommendations rather than one medication being universally superior. Our clinical team can guide you through the difference between Wegovy and Mounjaro UK based on your specific circumstances, ensuring informed treatment selection. Apply discount code FIRST40 for new customers or DOSE25 for returning customers at checkout to access our competitive pricing structure. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which treatment aligns with your weight management goals under proper medical supervision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
